<SEC-DOCUMENT>0001104659-21-119266.txt : 20211029
<SEC-HEADER>0001104659-21-119266.hdr.sgml : 20211029
<ACCEPTANCE-DATETIME>20210924153252
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001104659-21-119266
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20210924

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Fossil Group, Inc.
		CENTRAL INDEX KEY:			0000883569
		STANDARD INDUSTRIAL CLASSIFICATION:	WATCHES, CLOCKS, CLOCKWORK OPERATED DEVICES/PARTS [3873]
		IRS NUMBER:				752018505
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1228

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		901 S CENTRAL EXPRESSWAY
		CITY:			RICHARDSON
		STATE:			TX
		ZIP:			75080
		BUSINESS PHONE:		9722342525

	MAIL ADDRESS:	
		STREET 1:		901 S CENTRAL EXPRESSWAY
		CITY:			RICHARDSON
		STATE:			TX
		ZIP:			75080

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	FOSSIL INC
		DATE OF NAME CHANGE:	19940218
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

                           <P STYLE="margin: 0pt">&nbsp;</P>

<P STYLE="padding-left: 1.5%; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm2126907d4_correspimg001.jpg" ALT="">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">September 24, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Via EDGAR</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">United States Securities and Exchange Commission</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Division of Corporation Finance</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Office of Life Sciences</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">100 F Street, N.E.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Washington, DC 20549</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 10%; text-align: left">Attention:</TD><TD STYLE="text-align: justify">Christine Westbrook <BR>
Celeste Murphy</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><B>Re:</B></TD><TD STYLE="text-align: justify"><B>Responses to the Securities and Exchange Commission <BR>
Staff
Comments dated September 21, 2021, regarding<BR>
 Fossil Group, Inc. <BR>
Registration Statement on Form S-3 <BR>
Filed September 7, 2021 <BR>
File No. 333-259352</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Ms. Westbrook and Ms. Murphy:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">On behalf of Fossil Group,
Inc. (the &#8220;<B><I>Company</I></B>&#8221;, &#8220;<B><I>Fossil</I></B>&#8221;, &#8220;<B><I>we</I></B>,&#8221; &#8220;<B><I>us</I></B>&#8221;
or &#8220;<B><I>our</I></B>&#8221;), I hereby submit the Company&#8217;s responses to the comments received from the staff (the &#8220;<B><I>Staff</I></B>&#8221;)
of the United States Securities and Exchange Commission (the &#8220;<B><I>Commission</I></B>&#8221;) set forth in the Staff&#8217;s letter
to the Company, dated September 21, 2021 (the &#8220;<B><I>Comment Letter</I></B>&#8221;), with respect to the Company&#8217;s Registration
Statement on Form S-3, File No. 333-259352, filed with the Commission via the Commission&#8217;s EDGAR system on September 7, 2021 (the
 &#8220;<B><I>Registration Statement</I></B>&#8221;). Concurrently with this letter, the Company is filing Amendment No. 1 to the Registration
Statement to respond to the comments contained in the Comment Letter and to make certain other changes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For your convenience, each
response below is preceded by the Staff&#8217;s comment to which the response relates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Cover page</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>1.</B></TD><TD><B>Please describe the recent price volatility in your stock and briefly disclose any known risks of
investing in your securities under these circumstances. For additional guidance, please see the Division of Corporation Finance's February
8, 2021 guidance &quot;Sample Letter to Companies Regarding Securities Offerings During Times of Extreme Price Volatility.&quot;</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B>Response:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>The Company respectfully acknowledges the
Staff&#8217;s comment and has revised the disclosure on the cover page in response to the Staff&#8217;s comment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">United States Securities and Exchange Commission</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Division of Corporation Finance</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">September 24, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page
</FONT>2</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>2.</B></TD><TD><B>Please add, for comparison purposes, disclosure of the market price of your common stock prior to
the recent market price volatility in your stock.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0.5in"><B>Response:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>The Company respectfully acknowledges
the Staff&#8217;s comment and has revised the disclosure on the cover page in response to the Staff&#8217;s comment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>3.</B></TD><TD><B>Please describe any recent change in your financial condition or results of operations, such as your
earnings, revenues or other measure of company value that is consistent with the recent change in your stock price. If no such change
to your financial condition or results of operations exist, disclose that fact.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0.5in"><B>Response:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>The Company respectfully acknowledges
the Staff&#8217;s comment and has revised the disclosure on the cover page in response to the Staff&#8217;s comment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Risk Factors, page 1 </U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>4.</B></TD><TD><B>Please include a risk factor addressing the recent extreme volatility in your stock price. Your disclosure should include intra-day
stock price range information and should cover a period of time sufficient to demonstrate the recent price volatility and should address
the impact on investors. Your disclosure should also address the potential for rapid and substantial decreases in your stock price, including
decreases unrelated to your operating performance or prospects. To the extent recent increases in your stock price are significantly inconsistent
with improvements in actual or expected operating performance, financial condition or other indicators of value, discuss the inconsistencies
and where relevant quantify them. If you lack information to do so, explain why.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0.5in"><B>Response:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>The Company
respectfully acknowledges the Staff&#8217;s comment and will add risk factors to any prospectus supplement used in connection with an
offering under the Registration Statement, to the extent such offering includes common stock-related risk factors. To facilitate the Staff&#8217;s
review of the Registration Statement, the Company has provided below its expected risk factors for any such prospectus supplement, subject
to modification due to the passage of time or the facts and circumstances of the offering. The Company will also  include such
risk factors in its next quarterly report on Form 10-Q.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">United States Securities and Exchange Commission</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Division of Corporation Finance</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">September 24, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page
</FONT>3</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B><I>Our shares of common stock have recently experienced
extreme volatility in market prices and trading volume and purchasers of our common stock could incur substantial losses due to similar
volatility in the future.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">The extreme volatility of the market prices and trading
volume that our shares of common stock have recently experienced, and may continue to experience, could cause purchasers of our
common stock to incur substantial losses. For example, from January&nbsp;1, 2021 to the date hereof, the market price of our common
stock has fluctuated from an intra-day low on the NASDAQ Global Select Market of $8.43 per share on January&nbsp;4, 2021 to
an&nbsp;intra-day&nbsp;high of $28.60 per share on January&nbsp;27, 2021. For comparison, during the month of December 2020, prior
to the recent onset of extreme volatility, the market price of our common stock on the NASDAQ Global Select Market fluctuated from
intra-day&nbsp;low of $8.38 per share on December 29, 2020 to an&nbsp;intra-day&nbsp;high of $13.61 per share on December 14, 2020.
Significant fluctuations in the market price of our common stock have been accompanied by reports of strong and atypical retail
investor interest, including on social media and online forums. The market volatility and trading patterns we have experienced
create several risks for investors, including the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; padding-left: 0.5in; font-size: 10pt">&#8226;</TD>
    <TD STYLE="padding-left: 0.5in; font-size: 10pt">the market price of our common stock may experience rapid and substantial increases or decreases unrelated to our operating performance, financial condition or business prospects, or macro or industry fundamentals; </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; padding-left: 0.5in; font-size: 10pt">&#8226;</TD>
    <TD STYLE="padding-left: 0.5in; font-size: 10pt">factors in the public trading market for our common stock may include the sentiment of retail investors (including as may be expressed on financial trading and other social media sites and online forums), the direct access by retail investors to broadly available trading platforms, the amount and status of short interest in our securities, access to margin debt, trading in options and other derivatives on our common stock and any related hedging and other trading factors; </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; padding-left: 0.5in; font-size: 10pt">&#8226;</TD>
    <TD STYLE="padding-left: 0.5in; font-size: 10pt">our market capitalization, as implied by various trading prices, has reflected valuations that diverge significantly from those seen prior to recent volatility and that are significantly higher than our market capitalization immediately prior to such recent volatility, which began on or about January 25, 2021, and to the extent these valuations reflect trading dynamics unrelated to our financial performance or business prospects, purchasers of our common stock could incur substantial losses if there are declines in market prices driven by a return to earlier valuations of the Company;&nbsp;&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; padding-left: 0.5in; font-size: 10pt">&#8226;</TD>
    <TD STYLE="padding-left: 0.5in; font-size: 10pt">to the extent volatility in our common stock is caused by a &#8220;short squeeze&#8221; in which coordinated trading activity causes a spike in the market price of our common stock as traders with a short position make market purchases to avoid or to mitigate potential losses, investors may purchase at inflated prices unrelated to our financial performance or prospects, and may thereafter suffer substantial losses as prices decline once the level of short-covering purchases has abated; and</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; padding-left: 0.5in; font-size: 10pt">&#8226;</TD>
    <TD STYLE="padding-left: 0.5in; font-size: 10pt">if the market price of our common stock declines, investors may be unable to resell their shares of common stock at or above the price at which they acquired them. </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">We cannot assure you that the market price of our common
stock will not fluctuate or decline significantly in the future, in which case investors could incur substantial losses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">United States Securities and Exchange Commission</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Division of Corporation Finance</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">September 24, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page
</FONT>4</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B><I>We may continue to incur rapid and substantial increases
or decreases in our stock price in the foreseeable future that may not coincide in timing with the disclosure of news or developments
by or affecting us. Accordingly, the market price of our common stock may fluctuate dramatically, and may decline rapidly, regardless
of any developments in our business. </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Overall, there are various factors, many of which are beyond
our control, that could negatively affect the market price of our common stock or result in fluctuations in the price or trading volume
of our common stock, including:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; padding-left: 0.5in; font-size: 10pt">&#8226;</TD>
    <TD STYLE="padding-left: 0.5in; font-size: 10pt">the ongoing impacts and developments relating to the COVID-19 pandemic; </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; padding-left: 0.5in; font-size: 10pt">&#8226;</TD>
    <TD STYLE="padding-left: 0.5in; font-size: 10pt">actual or anticipated variations in our annual or quarterly results of operations, including our earnings estimates and whether we meet market expectations with regard to our earnings; </TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; padding-left: 0.5in; font-size: 10pt">&#8226;</TD>
    <TD STYLE="padding-left: 0.5in; font-size: 10pt">our current inability to pay dividends or other distributions; </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; padding-left: 0.5in; font-size: 10pt">&#8226;</TD>
    <TD STYLE="padding-left: 0.5in; font-size: 10pt">publication of research reports by analysts or others about us or the specialty retail industry, which may be unfavorable, inaccurate, inconsistent or not disseminated on a regular basis; </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; padding-left: 0.5in; font-size: 10pt">&#8226;</TD>
    <TD STYLE="padding-left: 0.5in; font-size: 10pt">changes in market valuations of similar companies; </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; padding-left: 0.5in; font-size: 10pt">&#8226;</TD>
    <TD STYLE="padding-left: 0.5in; font-size: 10pt">market reaction to any additional equity, debt or other securities that we may issue in the future, and which may or may not dilute the holdings of our existing stockholders; </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; padding-left: 0.5in; font-size: 10pt">&#8226;</TD>
    <TD STYLE="padding-left: 0.5in; font-size: 10pt">additions or departures of key personnel; </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; padding-left: 0.5in; font-size: 10pt">&#8226;</TD>
    <TD STYLE="padding-left: 0.5in; font-size: 10pt">actions by institutional or significant stockholders; </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; padding-left: 0.5in; font-size: 10pt">&#8226;</TD>
    <TD STYLE="padding-left: 0.5in; font-size: 10pt">short interest in our stock and the market response to such short interest; </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; padding-left: 0.5in; font-size: 10pt">&#8226;</TD>
    <TD STYLE="padding-left: 0.5in; font-size: 10pt">a dramatic increase in the number of individual holders of our stock and their participation in social media platforms targeted at speculative investing; </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; padding-left: 0.5in; font-size: 10pt">&#8226;</TD>
    <TD STYLE="padding-left: 0.5in; font-size: 10pt">speculation in the press or investment community about our company or industry; </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; padding-left: 0.5in; font-size: 10pt">&#8226;</TD>
    <TD STYLE="padding-left: 0.5in; font-size: 10pt">strategic actions by us or our competitors, such as acquisitions or other investments; </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; padding-left: 0.5in; font-size: 10pt">&#8226;</TD>
    <TD STYLE="padding-left: 0.5in; font-size: 10pt">legislative, administrative, regulatory or other actions affecting our business, our industry, including positions taken by the Internal Revenue Service (&#8220;IRS&#8221;); </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; padding-left: 0.5in; font-size: 10pt">&#8226;</TD>
    <TD STYLE="padding-left: 0.5in; font-size: 10pt">investigations, proceedings, or litigation that involve or affect us; </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; padding-left: 0.5in; font-size: 10pt">&#8226;</TD>
    <TD STYLE="padding-left: 0.5in; font-size: 10pt">the occurrence of any of the other risk factors included or incorporated by reference in this prospectus; and </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; padding-left: 0.5in; font-size: 10pt">&#8226;</TD>
    <TD STYLE="padding-left: 0.5in; font-size: 10pt">general market and economic conditions. </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.15in 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><B>5.</B></TD><TD><B>Please include a risk factor addressing the effects of a potential &quot;short squeeze&quot; due
to a sudden increase in demand for your stock. Among other things, your disclosure should describe what typically happens following a
short squeeze and address the impact on investors that purchase shares during this time.</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 0.5in"><B>Response:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B>The Company
respectfully acknowledges the Staff&#8217;s comment and will add a risk factor to any prospectus supplement used in connection with an
offering under the Registration Statement, to the extent such offering includes common stock-related risk factors. To facilitate the Staff&#8217;s
review of the Registration Statement, the Company has provided below its expected risk factor for any such prospectus supplement, subject
to modification due to the passage of time or the facts and circumstances of the offering. The Company will also  include such
risk factor in its next quarterly report on Form 10-Q.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">United States Securities and Exchange Commission</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Division of Corporation Finance</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">September 24, 2021</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page
</FONT>5</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B><I>A &#8220;short squeeze&#8221; due to a sudden increase
in demand of our common stock that largely exceeds supply may lead to additional price volatility.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Investors may purchase shares of our common stock to hedge
existing exposure or to speculate on the price of our common stock. Speculation on the price of our common stock may involve long and
short exposures. To the extent aggregate short exposure exceeds the number of shares of our common stock available for purchase on the
open market, investors with short exposure may have to pay a premium to repurchase shares of our common stock for delivery to lenders
of our common stock. Those repurchases may in turn, dramatically increase the price of our common stock until additional shares of our
common stock are available for trading or borrowing. This is often referred to as a &#8220;short squeeze.&#8221; A proportion of our common
stock has been and may continue to be traded by short sellers which may increase the likelihood that our common stock will be the target
of a short squeeze. A short squeeze could lead to volatile price movements in shares of our common stock that are unrelated or disproportionate
to our operating performance or prospectus and, once investors purchase the shares of our common stock necessary to cover their short
positions, the price of our common stock may rapidly decline. Investors that purchase shares of our common stock during a short squeeze
may lose a significant portion of their investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.15in 0pt 0; text-align: center">* * * * *</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.15in 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.15in 0pt 0; text-align: justify; text-indent: 0.5in">If you have any
questions regarding the foregoing, please contact me at (972)&nbsp;699-2115, or Garrett DeVries or Cynthia Mabry of Akin Gump Strauss
Hauer &amp; Feld LLP at (214)&nbsp;969-2891 or (713) 220-8130.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.05in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sincerely,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fossil Group, Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid">/s/ Randy S. Hyne</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Randy S. Hyne</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vice President, General Counsel and Secretary</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.05in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.4in; text-align: left">cc:</TD><TD STYLE="text-align: justify">Mr. Garrett DeVries </TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">Ms. Cynthia Mabry</TD></TR>
     </TABLE>



<P STYLE="margin: 0pt">&nbsp;</P>

<P STYLE="margin: 0pt"></P>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>tm2126907d4_correspimg001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2126907d4_correspimg001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !* ,,# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#N_B)\3)O
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M$UZ]87]KJEA#?64Z3VTZ[XY$/#"O.]=^"/AS4KJ.XT\RZ>?,0RQ1MF-D!^8
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M)].::EI\+?#?B^WMX7^Q:Q;3*HB0W!!=@-H;J".0>OUH ]1)P,GI5?[?9_\
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2%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
